US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
(OP:
CNTGF
)
0.1200
UNCHANGED
Last Price
Updated: 10:54 AM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CNTGF
CENTOGENE Closes Strategic Transaction with Private Equity Group Charme Capital Partners
March 12, 2025
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Voting Results of Extraordinary General Meeting
December 04, 2024
Approval of All Resolutions, Including Announced Transaction With Charme Capital Partners
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners
November 13, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
September 25, 2024
From
Centogene NV
Via
GlobeNewswire
